_id

695fbc26c2e91020a7bd438e

Ticker

0KCS.LSE

Name

OPKO Health, Inc.

Exchange

LSE

Address

4400 Biscayne Boulevard, Miami, FL, United States, 33137

Country

UK

Sector

Industry

Currency

USD

Website

https://www.opko.com

Description

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, immunology, and infectious diseases; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins or peptides; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products for a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Spain, Ireland, Chile, and Mexico. OPKO Health, Inc. was founded in 2007 and is headquartered in Miami, Florida.

Last Close

1.33

Volume

5824

Current Price

1.3395

Last Updated

2026-01-08T14:16:05.834Z

Ipo Date

-

Market Cap

61630918400

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2025-09-30

Revenue

151669000

Cost Of Revenue

80402000

Gross Profit

71267000

Operating Expenses

23211000

Operating Income

48056000

Interest Expense

11358000

Pretax Income

41431000

Net Income

61228000

Eps

0.0785055623302668

Dividends Per Share

-

Shares Outstanding

559827968

Income Tax Expense

-19797000

EBITDA

75529000

Operating Margin

31.684787267009078

Total Other Income Expense Net

-6625000

Cash

415198000

Short Term Investments

-

Receivables

124378000

Inventories

64954000

Total Current Assets

627130000

Property Plant Equipment

120675000

Total Assets

1995508000

Payables

50827000

Short Term Debt

24349000

Long Term Debt

-

Total Liabilities

690018000

Equity

1305490000

Bs_currency_symbol

-

Depreciation

22740000

Change In Working Capital

-1880000

Cash From Operations

-34647000

Capital Expenditures

3135000

Cash From Investing

194648000

Cash From Financing

-16206000

Net Change In Cash

143479000

Cf_currency_symbol

-

PE

-

PB

0.8002373418643574

ROE

4.6900397551877075

ROA

3.068291382444971

FCF

-37782000

Fcf Percent

-0.24910825547738827

Piotroski FScore

2

Health Score

51

Deep Value Investing Score

7

Defensive Investing Score

6.5

Dividend Investing Score

1.5

Economic Moat Investing Score

6.3

Garp Investing Score

2

Growth Investing Score

1

Momentum Investing Score

3.5

Net Net Investing Score

2.5

Quality Investing Score

5.5

Value Investing Score

7.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

151669000

Quarters > 0 > income Statement > cost Of Revenue

80402000

Quarters > 0 > income Statement > gross Profit

71267000

Quarters > 0 > income Statement > operating Expenses

23211000

Quarters > 0 > income Statement > operating Income

48056000

Quarters > 0 > income Statement > interest Expense

11358000

Quarters > 0 > income Statement > pretax Income

41431000

Quarters > 0 > income Statement > net Income

61228000

Quarters > 0 > income Statement > eps

0.0785055623302668

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

779919259

Quarters > 0 > income Statement > income Tax Expense

-19797000

Quarters > 0 > income Statement > EBITDA

75529000

Quarters > 0 > income Statement > operating Margin

31.684787267009078

Quarters > 0 > income Statement > total Other Income Expense Net

-6625000

Quarters > 0 > income Statement > currency_symbol

-

Quarters > 0 > balance Sheet > cash

415198000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

124378000

Quarters > 0 > balance Sheet > inventories

64954000

Quarters > 0 > balance Sheet > total Current Assets

627130000

Quarters > 0 > balance Sheet > property Plant Equipment

120675000

Quarters > 0 > balance Sheet > total Assets

1995508000

Quarters > 0 > balance Sheet > payables

50827000

Quarters > 0 > balance Sheet > short Term Debt

24349000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

690018000

Quarters > 0 > balance Sheet > equity

1305490000

Quarters > 0 > balance Sheet > currency_symbol

-

Quarters > 0 > cash Flow > net Income

21631000

Quarters > 0 > cash Flow > depreciation

22740000

Quarters > 0 > cash Flow > change In Working Capital

-1880000

Quarters > 0 > cash Flow > cash From Operations

-34647000

Quarters > 0 > cash Flow > capital Expenditures

3135000

Quarters > 0 > cash Flow > cash From Investing

194648000

Quarters > 0 > cash Flow > cash From Financing

-16206000

Quarters > 0 > cash Flow > net Change In Cash

143479000

Quarters > 0 > cash Flow > currency_symbol

-

Quarters > 0 > ratios > PE

0.0785055623302668

Quarters > 0 > ratios > PB

0.8002373418643574

Quarters > 0 > ratios > ROE

4.6900397551877075

Quarters > 0 > ratios > ROA

3.068291382444971

Quarters > 0 > ratios > FCF

-37782000

Quarters > 0 > ratios > Piotroski FScore

2

Quarters > 0 > ratios > fcf Percent

-0.24910825547738827

Quarters > 0 > health Score

51

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

156807000

Quarters > 1 > income Statement > cost Of Revenue

107405000

Quarters > 1 > income Statement > gross Profit

49402000

Quarters > 1 > income Statement > operating Expenses

109383000

Quarters > 1 > income Statement > operating Income

-59981000

Quarters > 1 > income Statement > interest Expense

70327000

Quarters > 1 > income Statement > pretax Income

-162520000

Quarters > 1 > income Statement > net Income

-148441000

Quarters > 1 > income Statement > eps

-0.2210334779183921

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

671577000

Quarters > 1 > income Statement > income Tax Expense

-14079000

Quarters > 1 > income Statement > EBITDA

-69166000

Quarters > 1 > income Statement > operating Margin

-38.25148112010306

Quarters > 1 > income Statement > total Other Income Expense Net

-102539000

Quarters > 1 > income Statement > currency_symbol

-

Quarters > 1 > balance Sheet > cash

271718000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

134577000

Quarters > 1 > balance Sheet > inventories

66345000

Quarters > 1 > balance Sheet > total Current Assets

583333000

Quarters > 1 > balance Sheet > property Plant Equipment

121564000

Quarters > 1 > balance Sheet > total Assets

1972989000

Quarters > 1 > balance Sheet > payables

56683000

Quarters > 1 > balance Sheet > short Term Debt

25509000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

676085000

Quarters > 1 > balance Sheet > equity

1296904000

Quarters > 1 > balance Sheet > currency_symbol

-

Quarters > 1 > cash Flow > net Income

-148441000

Quarters > 1 > cash Flow > depreciation

23027000

Quarters > 1 > cash Flow > change In Working Capital

-37871000

Quarters > 1 > cash Flow > cash From Operations

-83420000

Quarters > 1 > cash Flow > capital Expenditures

3283000

Quarters > 1 > cash Flow > cash From Investing

-2834000

Quarters > 1 > cash Flow > cash From Financing

-79489000

Quarters > 1 > cash Flow > net Change In Cash

-164282000

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

-0.2210334779183921

Quarters > 1 > ratios > PB

0.6936345261484272

Quarters > 1 > ratios > ROE

-11.445797067477624

Quarters > 1 > ratios > ROA

-7.523660800947192

Quarters > 1 > ratios > FCF

-86703000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-0.5529281218312958

Quarters > 1 > health Score

30

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

149952000

Quarters > 2 > income Statement > cost Of Revenue

107332000

Quarters > 2 > income Statement > gross Profit

42620000

Quarters > 2 > income Statement > operating Expenses

109788000

Quarters > 2 > income Statement > operating Income

-67168000

Quarters > 2 > income Statement > interest Expense

15466000

Quarters > 2 > income Statement > pretax Income

-73374000

Quarters > 2 > income Statement > net Income

-67613000

Quarters > 2 > income Statement > eps

-0.1006779565113159

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

671577000

Quarters > 2 > income Statement > income Tax Expense

-5761000

Quarters > 2 > income Statement > EBITDA

-34421000

Quarters > 2 > income Statement > operating Margin

-44.79300042680324

Quarters > 2 > income Statement > total Other Income Expense Net

-6206000

Quarters > 2 > income Statement > currency_symbol

-

Quarters > 2 > balance Sheet > cash

435999000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

128718000

Quarters > 2 > balance Sheet > inventories

64001000

Quarters > 2 > balance Sheet > total Current Assets

737604000

Quarters > 2 > balance Sheet > property Plant Equipment

119014000

Quarters > 2 > balance Sheet > total Assets

2128327000

Quarters > 2 > balance Sheet > payables

59370000

Quarters > 2 > balance Sheet > short Term Debt

124893000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

816664000

Quarters > 2 > balance Sheet > equity

1311663000

Quarters > 2 > balance Sheet > currency_symbol

-

Quarters > 2 > cash Flow > net Income

-67613000

Quarters > 2 > cash Flow > depreciation

23487000

Quarters > 2 > cash Flow > change In Working Capital

10698000

Quarters > 2 > cash Flow > cash From Operations

-34554000

Quarters > 2 > cash Flow > capital Expenditures

3194000

Quarters > 2 > cash Flow > cash From Investing

40528000

Quarters > 2 > cash Flow > cash From Financing

-4022000

Quarters > 2 > cash Flow > net Change In Cash

4062000

Quarters > 2 > cash Flow > currency_symbol

USD

Quarters > 2 > ratios > PE

-0.1006779565113159

Quarters > 2 > ratios > PB

0.6858296616585204

Quarters > 2 > ratios > ROE

-5.154753926885183

Quarters > 2 > ratios > ROA

-3.176814465070452

Quarters > 2 > ratios > FCF

-37748000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-0.25173388817755016

Quarters > 2 > health Score

30

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

183638000

Quarters > 3 > income Statement > cost Of Revenue

98979000

Quarters > 3 > income Statement > gross Profit

84659000

Quarters > 3 > income Statement > operating Expenses

117798000

Quarters > 3 > income Statement > operating Income

-33139000

Quarters > 3 > income Statement > interest Expense

14240000

Quarters > 3 > income Statement > pretax Income

34984000

Quarters > 3 > income Statement > net Income

14027000

Quarters > 3 > income Statement > eps

0.020211233105674187

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

694020000

Quarters > 3 > income Statement > income Tax Expense

20946000

Quarters > 3 > income Statement > EBITDA

73179000

Quarters > 3 > income Statement > operating Margin

-18.045829294590444

Quarters > 3 > income Statement > total Other Income Expense Net

68123000

Quarters > 3 > income Statement > currency_symbol

-

Quarters > 3 > balance Sheet > cash

431936000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

152048000

Quarters > 3 > balance Sheet > inventories

56797000

Quarters > 3 > balance Sheet > total Current Assets

662089000

Quarters > 3 > balance Sheet > property Plant Equipment

124137000

Quarters > 3 > balance Sheet > total Assets

2200212000

Quarters > 3 > balance Sheet > payables

47071000

Quarters > 3 > balance Sheet > short Term Debt

29347000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

834764000

Quarters > 3 > balance Sheet > equity

1365448000

Quarters > 3 > balance Sheet > currency_symbol

-

Quarters > 3 > cash Flow > net Income

14027000

Quarters > 3 > cash Flow > depreciation

24039000

Quarters > 3 > cash Flow > change In Working Capital

-16976000

Quarters > 3 > cash Flow > cash From Operations

-44409000

Quarters > 3 > cash Flow > capital Expenditures

5413000

Quarters > 3 > cash Flow > cash From Investing

115987000

Quarters > 3 > cash Flow > cash From Financing

-40472000

Quarters > 3 > cash Flow > net Change In Cash

25550000

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

0.020211233105674187

Quarters > 3 > ratios > PB

0.6808313388719306

Quarters > 3 > ratios > ROE

1.027281888435151

Quarters > 3 > ratios > ROA

0.6375294744324638

Quarters > 3 > ratios > FCF

-49822000

Quarters > 3 > ratios > Piotroski FScore

2

Quarters > 3 > ratios > fcf Percent

-0.27130550321828817

Quarters > 3 > health Score

46

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

713142000

Annuals > 0 > income Statement > cost Of Revenue

402109000

Annuals > 0 > income Statement > gross Profit

311033000

Annuals > 0 > income Statement > operating Expenses

463098000

Annuals > 0 > income Statement > operating Income

-152065000

Annuals > 0 > income Statement > interest Expense

47465000

Annuals > 0 > income Statement > pretax Income

-10362000

Annuals > 0 > income Statement > net Income

-53224000

Annuals > 0 > income Statement > eps

-0.07668943258119362

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

694020000

Annuals > 0 > income Statement > income Tax Expense

42844000

Annuals > 0 > income Statement > EBITDA

135279000

Annuals > 0 > income Statement > operating Margin

-21.323242776333466

Annuals > 0 > income Statement > total Other Income Expense Net

141703000

Annuals > 0 > income Statement > currency_symbol

-

Annuals > 0 > balance Sheet > cash

431936000

Annuals > 0 > balance Sheet > short Term Investments

-

Annuals > 0 > balance Sheet > receivables

152048000

Annuals > 0 > balance Sheet > inventories

56797000

Annuals > 0 > balance Sheet > total Current Assets

662089000

Annuals > 0 > balance Sheet > property Plant Equipment

124137000

Annuals > 0 > balance Sheet > total Assets

2200212000

Annuals > 0 > balance Sheet > payables

47071000

Annuals > 0 > balance Sheet > short Term Debt

29347000

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

834764000

Annuals > 0 > balance Sheet > equity

1365448000

Annuals > 0 > balance Sheet > currency_symbol

-

Annuals > 0 > cash Flow > net Income

-53224000

Annuals > 0 > cash Flow > depreciation

98176000

Annuals > 0 > cash Flow > change In Working Capital

32175000

Annuals > 0 > cash Flow > cash From Operations

-183489000

Annuals > 0 > cash Flow > capital Expenditures

25010000

Annuals > 0 > cash Flow > cash From Investing

352214000

Annuals > 0 > cash Flow > cash From Financing

184166000

Annuals > 0 > cash Flow > net Change In Cash

349734000

Annuals > 0 > cash Flow > currency_symbol

-

Annuals > 0 > ratios > PE

-0.07668943258119362

Annuals > 0 > ratios > PB

0.6808313388719306

Annuals > 0 > ratios > ROE

-3.89791482355974

Annuals > 0 > ratios > ROA

-2.4190396198184536

Annuals > 0 > ratios > FCF

-208499000

Annuals > 0 > ratios > Piotroski FScore

0

Annuals > 0 > ratios > fcf Percent

-0.2923667376202776

Annuals > 0 > health Score

29

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

863495000

Annuals > 1 > income Statement > cost Of Revenue

545368000

Annuals > 1 > income Statement > gross Profit

318127000

Annuals > 1 > income Statement > operating Expenses

475148000

Annuals > 1 > income Statement > operating Income

-157021000

Annuals > 1 > income Statement > interest Expense

13506000

Annuals > 1 > income Statement > pretax Income

-184426000

Annuals > 1 > income Statement > net Income

-188863000

Annuals > 1 > income Statement > eps

-0.2512257803625064

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

751766000

Annuals > 1 > income Statement > income Tax Expense

4437000

Annuals > 1 > income Statement > EBITDA

-65516000

Annuals > 1 > income Statement > operating Margin

-18.184355439232423

Annuals > 1 > income Statement > total Other Income Expense Net

-27405000

Annuals > 1 > income Statement > currency_symbol

-

Annuals > 1 > balance Sheet > cash

95881000

Annuals > 1 > balance Sheet > short Term Investments

-

Annuals > 1 > balance Sheet > receivables

130200000

Annuals > 1 > balance Sheet > inventories

65697000

Annuals > 1 > balance Sheet > total Current Assets

309476000

Annuals > 1 > balance Sheet > property Plant Equipment

143517000

Annuals > 1 > balance Sheet > total Assets

2011698000

Annuals > 1 > balance Sheet > payables

69677000

Annuals > 1 > balance Sheet > short Term Debt

43116000

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

622479000

Annuals > 1 > balance Sheet > equity

1389219000

Annuals > 1 > balance Sheet > currency_symbol

-

Annuals > 1 > cash Flow > net Income

-188863000

Annuals > 1 > cash Flow > depreciation

105297000

Annuals > 1 > cash Flow > change In Working Capital

21799000

Annuals > 1 > cash Flow > cash From Operations

-28197000

Annuals > 1 > cash Flow > capital Expenditures

16275000

Annuals > 1 > cash Flow > cash From Investing

-18198000

Annuals > 1 > cash Flow > cash From Financing

-11303000

Annuals > 1 > cash Flow > net Change In Cash

-57310000

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

-0.2512257803625064

Annuals > 1 > ratios > PB

0.724860916097462

Annuals > 1 > ratios > ROE

-13.594904763035922

Annuals > 1 > ratios > ROA

-9.388238194798623

Annuals > 1 > ratios > FCF

-44472000

Annuals > 1 > ratios > Piotroski FScore

1

Annuals > 1 > ratios > fcf Percent

-0.051502324854226136

Annuals > 1 > health Score

34

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

1004196000

Annuals > 2 > income Statement > cost Of Revenue

715977000

Annuals > 2 > income Statement > gross Profit

288219000

Annuals > 2 > income Statement > operating Expenses

514472000

Annuals > 2 > income Statement > operating Income

-226253000

Annuals > 2 > income Statement > interest Expense

12056000

Annuals > 2 > income Statement > pretax Income

-391904000

Annuals > 2 > income Statement > net Income

-328405000

Annuals > 2 > income Statement > eps

-0.45671368632146647

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

719061000

Annuals > 2 > income Statement > income Tax Expense

-63499000

Annuals > 2 > income Statement > EBITDA

-270810000

Annuals > 2 > income Statement > operating Margin

-22.53076092714968

Annuals > 2 > income Statement > total Other Income Expense Net

-165651000

Annuals > 2 > income Statement > currency_symbol

-

Annuals > 2 > balance Sheet > cash

153191000

Annuals > 2 > balance Sheet > short Term Investments

-

Annuals > 2 > balance Sheet > receivables

148608000

Annuals > 2 > balance Sheet > inventories

74060000

Annuals > 2 > balance Sheet > total Current Assets

394525000

Annuals > 2 > balance Sheet > property Plant Equipment

121604000

Annuals > 2 > balance Sheet > total Assets

2167259000

Annuals > 2 > balance Sheet > payables

66993000

Annuals > 2 > balance Sheet > short Term Debt

51027000

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

605611000

Annuals > 2 > balance Sheet > equity

1561648000

Annuals > 2 > balance Sheet > currency_symbol

-

Annuals > 2 > cash Flow > net Income

-328405000

Annuals > 2 > cash Flow > depreciation

108655000

Annuals > 2 > cash Flow > change In Working Capital

42654000

Annuals > 2 > cash Flow > cash From Operations

-95189000

Annuals > 2 > cash Flow > capital Expenditures

24578000

Annuals > 2 > cash Flow > cash From Investing

91038000

Annuals > 2 > cash Flow > cash From Financing

22971000

Annuals > 2 > cash Flow > net Change In Cash

18481000

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

-0.45671368632146647

Annuals > 2 > ratios > PB

0.616772928022192

Annuals > 2 > ratios > ROE

-21.029386904091062

Annuals > 2 > ratios > ROA

-15.15301124600244

Annuals > 2 > ratios > FCF

-119767000

Annuals > 2 > ratios > Piotroski FScore

1

Annuals > 2 > ratios > fcf Percent

-0.11926655752462667

Annuals > 2 > health Score

34

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

1774718000

Annuals > 3 > income Statement > cost Of Revenue

1193194000

Annuals > 3 > income Statement > gross Profit

581524000

Annuals > 3 > income Statement > operating Expenses

562774000

Annuals > 3 > income Statement > operating Income

18750000

Annuals > 3 > income Statement > interest Expense

18880000

Annuals > 3 > income Statement > pretax Income

-14654000

Annuals > 3 > income Statement > net Income

-30143000

Annuals > 3 > income Statement > eps

-0.04651137671700011

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

648078000

Annuals > 3 > income Statement > income Tax Expense

15489000

Annuals > 3 > income Statement > EBITDA

83571000

Annuals > 3 > income Statement > operating Margin

1.0565058786804438

Annuals > 3 > income Statement > total Other Income Expense Net

-33404000

Annuals > 3 > income Statement > currency_symbol

-

Annuals > 3 > balance Sheet > cash

134710000

Annuals > 3 > balance Sheet > short Term Investments

-

Annuals > 3 > balance Sheet > receivables

265588000

Annuals > 3 > balance Sheet > inventories

86502000

Annuals > 3 > balance Sheet > total Current Assets

823013000

Annuals > 3 > balance Sheet > property Plant Equipment

123955000

Annuals > 3 > balance Sheet > total Assets

2399715000

Annuals > 3 > balance Sheet > payables

82040000

Annuals > 3 > balance Sheet > short Term Debt

28575000

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

714589000

Annuals > 3 > balance Sheet > equity

1685126000

Annuals > 3 > balance Sheet > currency_symbol

-

Annuals > 3 > cash Flow > net Income

-30143000

Annuals > 3 > cash Flow > depreciation

78716000

Annuals > 3 > cash Flow > change In Working Capital

-20482000

Annuals > 3 > cash Flow > cash From Operations

38337000

Annuals > 3 > cash Flow > capital Expenditures

32156000

Annuals > 3 > cash Flow > cash From Investing

35949000

Annuals > 3 > cash Flow > cash From Financing

-10350000

Annuals > 3 > cash Flow > net Change In Cash

62499000

Annuals > 3 > cash Flow > currency_symbol

USD

Annuals > 3 > ratios > PE

-0.04651137671700011

Annuals > 3 > ratios > PB

0.51515464184874

Annuals > 3 > ratios > ROE

-1.7887683176213527

Annuals > 3 > ratios > ROA

-1.256107496098495

Annuals > 3 > ratios > FCF

6181000

Annuals > 3 > ratios > Piotroski FScore

2

Annuals > 3 > ratios > fcf Percent

0.003482806845932706

Annuals > 3 > health Score

33

Valuation > metrics > PE

0.0785055623302668

Valuation > metrics > PB

0.8002373418643574

Valuation > final Score

90

Valuation > verdict

59.6% Undervalued

Profitability > metrics > ROE

4.6900397551877075

Profitability > metrics > ROA

9.763206990576116

Profitability > metrics > Net Margin

0.403694888210511

Profitability > final Score

69

Profitability > verdict

Adequate

Risk > metrics > Debt Equity

0.528550965537844

Risk > metrics > Interest Coverage

4.231026589188238

Risk > final Score

65

Risk > verdict

High

Liquidity > metrics > Current Ratio

8.342157071405769

Liquidity > metrics > Quick Ratio

7.478131318505906

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

90

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

20

Prev Risks > 0

45

Prev Risks > 1

31

Prev Risks > 2

39

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T23:13:54.520Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-02-26

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

AfterMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

-0.07

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-